ESTRO shared on X:
“STORM trial results on the treatment of pelvic nodal oligo-recurrence after Prostate Cancer, presented at ESTRO 24: ENRT improves biochemical and locoregional relapse-free survival rates compared with SBRT.”
Further information.
Source: ESTRO/X
Other posts Featuring ESTRO on OncoDaily.